Tumor specific peripheral blood T lymphocyte responses to cancer vax [Canvaxin™] and BCG in patients with stage I uveal melanoma
Phase of Trial: Phase I
Latest Information Update: 08 Dec 2005
At a glance
- Drugs Cancer vaccine (Primary) ; BCG; Cancer vaccines
- Indications Eye neoplasms; Malignant melanoma
- Focus Therapeutic Use
- 08 Dec 2005 New trial record.